{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T10:11:25Z","timestamp":1693476685173},"reference-count":27,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Urology and Nephrology"],"published-print":{"date-parts":[[2004,1,1]]},"DOI":"10.1080\/00365590310019990","type":"journal-article","created":{"date-parts":[[2004,3,4]],"date-time":"2004-03-04T20:27:15Z","timestamp":1078432035000},"page":"15-18","source":"Crossref","is-referenced-by-count":4,"title":["The potentially curable prostate cancer patient and the pathways leading to diagnosis and treatment"],"prefix":"10.1080","volume":"38","author":[{"given":"Peder","family":"Gjengst\u00f8","sequence":"first","affiliation":[{"name":"Section of Urology, Department of Surgery, The Gade Institute, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Eide","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Gade Institute, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jannicke","family":"Frug\u00e5rd","sequence":"additional","affiliation":[{"name":"Section of Urology, Department of Surgery, The Gade Institute, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"August","family":"Bakke","sequence":"additional","affiliation":[{"name":"Section of Urology, Department of Surgery, The Gade Institute, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per \u00c5ge","family":"H\u00f8is\u00e6ter","sequence":"additional","affiliation":[{"name":"Section of Urology, Department of Surgery, The Gade Institute, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"CIT0001","first-page":"289","volume":"273","author":"Gann PH","year":"1995","journal-title":"A prospective evaluation of plasma prostate-specific antigen for detec-tion of prostatic cancer. JAMA"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/bmj.311.7016.1340","volume":"311","author":"Parkes C","year":"1995","journal-title":"Br Med J"},{"key":"CIT0003","first-page":"1594","volume":"344","author":"Stenman UH","year":"1994","journal-title":"Aromaa A, Teppo L, Leinonen J. Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet"},{"key":"CIT0004","author":"American Urological Society","year":"1992","journal-title":"Executive Committee Report. Baltimore"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.51.1.38"},{"key":"CIT0006","first-page":"82","volume":"166","author":"Carey JM","year":"2001","journal-title":"Do enemas decrease clinically significant complications? J Urol"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)00447-7"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0022-5347(01)62748-4","volume":"160","author":"Bova GS","year":"1998","journal-title":"J Urol"},{"key":"CIT0009","first-page":"272","volume":"35","author":"Bratt","year":"1999","journal-title":"Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur J Cancer"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0090-4295(97)00620-1","volume":"51","author":"Orozco R","year":"1998","journal-title":"Urology"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65851-X"},{"key":"CIT0012","doi-asserted-by":"crossref","unstructured":"Bran 0. Hereditary prostate cancer. BJU Int 2000; 85: 588\u201398.","DOI":"10.1046\/j.1464-410x.2000.00457.x"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0022-5347(01)66705-3","volume":"154","author":"Keetch DW","year":"1995","journal-title":"J Urol"},{"key":"CIT0014","unstructured":"Fossa SD, Hoiswter PA, Bjerklund Johansen T, Vatten L, Myhre KI Screening for prostata heft. Dokumentasjons-grunnlaget for den helsemessige effekten ved rutinemes-sig screening. Senter for medisinsk metodevurdering, SINTEF Unimed, SMM-rapport 3\/1999."},{"key":"CIT0015","first-page":"181","volume":"23","author":"Potosky AL","year":"2001","journal-title":"Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev"},{"key":"CIT0016","first-page":"2144","volume":"154","author":"Middleton RG","year":"1995","journal-title":"The American Urological Association. J Urol"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0022-5347(01)61628-8","volume":"161","author":"Meyer F","year":"1999","journal-title":"J Urol"},{"key":"CIT0018","first-page":"529","volume":"161","author":"Roberts RO","year":"1999","journal-title":"Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota. J Urol"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.20.1719"},{"key":"CIT0020","first-page":"416","volume":"166","author":"Han M","year":"2001","journal-title":"Era specific biochemical recurrence-free survival follow-ing radical prostatectomy for clinically localized prostate cancer. J Urol"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/107327480100800203","volume":"8","author":"Cookson MM","year":"2001","journal-title":"Cancer Control"},{"key":"CIT0022","first-page":"106","volume":"52","author":"Perrotti M","year":"1998","journal-title":"Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumours. Urology"},{"key":"CIT0023","first-page":"811","volume":"160","author":"Perrotti M","year":"1998","journal-title":"Trends in poorly differentiated prostate cancer 1973 to 1994: observations from the Surveillance, Epidemiol-ogy and End Results database. J Urol"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00257-5"},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1464-4096.2001.02449.x","volume":"88","author":"Schroder FH","year":"2001","journal-title":"BJU Int"},{"key":"CIT0026","first-page":"1333","volume":"156","author":"Wolf AM","year":"1996","journal-title":"The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med"},{"key":"CIT0027","first-page":"425","volume":"49","author":"Volk RJ","year":"2000","journal-title":"J Fam Pract"}],"container-title":["Scandinavian Journal of Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00365590310019990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T15:11:48Z","timestamp":1624461108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00365590310019990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1,1]]}},"alternative-id":["10.1080\/00365590310019990"],"URL":"https:\/\/doi.org\/10.1080\/00365590310019990","relation":{},"ISSN":["0036-5599","1651-2065"],"issn-type":[{"value":"0036-5599","type":"print"},{"value":"1651-2065","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,1]]}}}